Local News: Villas, NJ 

 | 

Sign Up

 | 

Sign In

Advertisment

Aceon, Perindopril

Aceon, Perindopril Wire

Comprehensive News Feed for Aceon, Perindopril (generic).

Results 1 - 20 of 43 in Aceon, Perindopril (generic)

  1. Role of Angiotensin II in the Remodeling Induced by a Chronic...

    Monday Nov 30 | Circulation

    From the Centre National de la Recherche Scientifique Unit Mixte de Recherche 6214 , Institut National de la Sant et de la Recherche Mdicale U771, Universit d'Angers, Angers, France; Centre Hospitalier Universitaire d'Angers , Angers, France; Institut National de la Sant et de la Recherche Mdicale U892 , Angers, France.

    Comment?

    Related Topix: France, Pays de La Loire, France, World News, Angers, France, Medicine, Atacand, Candesartan (generic)

  2. Roxane Labs receives FDA approval for heart disease drug

    Wednesday Nov 11 | Drug Store News

    COLUMBUS,A Ohio The Food and Drug Administration has approved Roxane Labsa generic version of a heart disease drug.

    Comment?

    Related Topix: Food and Drug Administration, Medicine, Medication

  3. FDA Approves Roxane Labs ANDA for Perindopril Erbumine TabletsRead the original story

    Wednesday Nov 11 | Pharmaceutical Processing

    Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application for Perindopril Erbumine Tablets, 2mg, 4mg and 8mg by the U.S. Food and Drug Administration.

    Comment?

    Related Topix: Medicine, Medication, Food and Drug Administration, Biotech, Healthcare Industry

  4. Roxane Laboratories, Inc. Announces the Launch of Perindopril Erbumine TabletsRead the original story

    Wednesday Nov 11 | Freshnews

    Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application for Perindopril Erbumine Tablets, 2mg, 4mg and 8mg by the U.S. Food and Drug Administration.

    Comment?

    Related Topix: Biotech, Medicine, Healthcare Industry, Medication, Drugs, Food and Drug Administration, 9

  5. ADVANCE Reveals New Insights in the Fight Against Severe Diabetes ComplicationsRead the original story

    Oct 20, 2009 | Canada NewsWire

    The new data from ADVANCE, presented today at the International Diabetes Federation Congress, show that the efficacy and safety of intensive blood glucose control using gliclazide modified release -based regimen is maintained across a broad range of patients in different clinical settings.

    Comment?

    Related Topix: 9

  6. Major study shows significant death risk reduction in type 2 diabetic ...Read the original story

    Oct 20, 2009 | Canada NewsWire

    The results were presented yesterday by Dr. Pavel Hamet , Chief of Gene Medicine Services at Centre hospitalier de l'Université de Montréal and professor of Medicine, Université de Montréal, the study's principal investigator for Canada , at the International Diabetes Federation Congress 2009 in Montreal and published in the ...

    Comment?

    Related Topix: Medicine, Diabetes, Health

  7. European Union Regulators Raid Drug Makers on Suspected Antitrust AbuseRead the original story

    Oct 8, 2009 | Pharmaceutical Processing

    The European Commission on Tuesday said it had visited the offices of several pharmaceutical companies that it did not name as part of an investigation into suspected monopoly abuse and restrictive business deals.

    Comment?

    Related Topix: Biotech, SanofiSynthlabo

  8. EU Raids Drug Makers Over Alleged Antitrust AbuseRead the original story

    Oct 7, 2009 | Manufacturing.net

    Drug makers Sanofi-Aventis SA, Novartis AG and Ratiopharm International GmbH said Wednesday that EU regulators had carried out surprise raids at their French offices as part of an antitrust probe.

    Comment?

    Related Topix: Biotech, SanofiSynthlabo

  9. EU raids drug makers on suspected antitrust abuseRead the original story

    Oct 7, 2009 | The Oregonian

    Drug makers Sanofi-Aventis SA, Novartis AG and Ratiopharm International GmbH said Wednesday that EU regulators had carried out surprise raids at their French offices as part of an antitrust probe.

    Comment?

    Related Topix: Biotech, SanofiSynthlabo, US Politics, US News

  10. EU says investigators raid pharma giantsRead the original story

    Oct 6, 2009 | The Tocqueville Connection

    Then, the commission said that unilateral behaviour by French pharmaceutical maker Les Laboratoires Servier might have hindered the entryinto EU markets of generic perindopril, a cardio-vascular medicine first developed by the company.

    Comment?

    Related Topix: Medicine, Medication

  11. EU warns of new antitrust probes for drug makersRead the original story

    Sep 29, 2009 | KIDK CBS 3 - News, Weather and Sports - Idaho Falls - Pocatello - Blackfoot, ID - Idaho Falls, Pocatello, Blackfoot - Idaho

    EU Competition Commissioner Neelie Kroes said regulators were capitalizing on a recent broad inquiry into the pharmaceutical sector that aimed to find out why generic versions of branded drugs were slow to come to the market and if innovation is held back.

    Comment?

  12. Drug makers warned of antitrust probesRead the original story

    Sep 29, 2009 | Shanghai Daily

    THE European Union's top antitrust official warned drug makers yesterday to "look out" for new investigations in coming months.

    Comment?

  13. Drug Makers Could Face EU Antitrust ProbesRead the original story

    Sep 29, 2009 | Manufacturing.net

    A -- The European Union's top antitrust official warned drug makers Tuesday to "look out" for new investigations in coming months.

    Comment?

  14. Combination of the angiotensin-converting enzyme inhibitor...

    Aug 13, 2009 | CiteULike

    We hypothesized that 1) hypertension abrogates postnatal vasculogenesis, and 2) antihypertensive treatment based on the combination of perindopril and indapamide may counteract hypertension-induced alteration in progenitor cell-related effects.

    Comment?

    Related Topix: Medicine, Medication, Lozol, Indapamide (generic)

  15. Treatment of hypertension in patients 80 years of age or older.

    Aug 13, 2009 | CiteULike

    Abstract BACKGROUND: Whether the treatment of patients with hypertension who are 80 years of age or older is beneficial is unclear.

    Comment?

    Related Topix: Lozol, Indapamide (generic), Medicine, Medication

  16. Some blood pressure drugs may help protect against dementiaRead the original story

    Jul 27, 2009 | Science, Industry and Business

    A particular class of medication used to treat high blood pressure could protect older adults against memory decline and other impairments in cognitive function, according to a newly published study from Wake Forest University School of Medicine.

    Comment?

    Related Topix: Wake Forest University, Medicine, Altace, Ramipril (generic)

  17. Some Blood Pressure Drugs May Help Protect Against Dementia, Study ShowsRead the original story

    Jul 24, 2009 | Science Daily

    Research suggests that some of the drugs classified as angiotensin-converting enzyme inhibitors, specifically those types of ACE inhibitors that affect the brain by crossing the blood-brain barrier, may reduce inflammation that could contribute to the development of Alzheimer's disease, a major cause of dementia.

    Comment?

    Related Topix: Wake Forest University, Medicine, Altace, Ramipril (generic)

  18. Some Blood Pressure Drugs May Protect Against DementiaRead the original story

    Jul 24, 2009 | News Max

    ACE inhibitor drugs, a class of drugs that treat high blood pressure, may help protect against dementia.

    Comment?

    Related Topix: Medicine, Hypertension, Health, Wake Forest University, Alzheimer's

  19. Blood Pressure Med Protects Memory DeclineRead the original story w/Photo

    Jul 24, 2009 | Psych Central News

    New research discovers a common class of blood pressure medication could protect older adults against memory decline and other impairments in cognitive function.

    Comment?

    Related Topix: Wake Forest University

  20. Some blood pressure drugs may help protect against dementia, study showsRead the original story

    Jul 23, 2009 | Medical News

    A particular class of medication used to treat high blood pressure could protect older adults against memory decline and other impairments in cognitive function, according to a newly published study from Wake Forest University School of Medicine .

    Comment?

    Related Topix: Wake Forest University, Health